THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
The paper provides information on the safety and diagnostic efficacy of macrocyclic magnetic resonance contrast agents, such as gadobutrol, gadoteridol, and gadoteric acid. It is concluded that the standard gadobutrol dose of 0.1 mmol/kg body weight has a favorable safety profile and is well tolerat...
Main Authors: | V. O. Panov, N. L. Shimanovskiy |
---|---|
Format: | Article |
Language: | English |
Published: |
LUCHEVAYA DIAGNOSTIKA, LLC
2017-07-01
|
Series: | Вестник рентгенологии и радиологии |
Subjects: | |
Online Access: | https://www.russianradiology.ru/jour/article/view/235 |
Similar Items
-
Pharmacoeconomic Evaluation of Using One-Molar Gadolinium-Based Magnetic Resonance Contrast Agent Compared to Half-Molar Agents for the Diagnosis of Multiple Sclerosis
by: A. A. Alikhanov, et al.
Published: (2020-11-01) -
Clinical and economic analysis of macrocyclic gadolinium-based compounds for use in magnetic resonance imaging diagnostics
by: A. E. Cheberda, et al.
Published: (2020-01-01) -
Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
by: Alessandra Splendiani, et al.
Published: (2019-09-01) -
Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?
by: V. O. Panov, et al.
Published: (2016-09-01) -
Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent
by: Meltem Özdemir, et al.
Published: (2019-07-01)